This an interesting fact: 11/16 Inovio has worked through the FDA’s questions about its COVID-19 vaccine delivery device, leading the agency to lift a partial clinical hold and clear the biotech to start enrolling subjects in the U.S. That means FDA didn’t stopped Cellectra